The present invention provides a panel of transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins. These transactivators have novel phenotypes such as altered basal transcriptional activity in the absence of doxycycline, altered induced transcriptional activity in the presence of doxycycline, or differential induction by tetracycline and analogs of tetracycline.

 
Web www.patentalert.com

< Rapid-Melt Compositions, Methods of Making Same and Methods of Using Same

> NOVEL HERBAL ACNE CONTROL COMPOSITION, METHOD OF MANUFACTURING THE SAME AND USE THEREOF

> Ketocarotenoids from Adonis palaestina

~ 00522